Development and Roll-Out of A Coronavirus Disease 2019 Clinical Pathway for Standardized Qualified Care in Public Hospitals in Korea.

IF 2.9
Mi Young Kwak, Eun Young Jo, BumSik Chin, Se Eun Park, Jun Yim, Jung Eun Lee, Kyung Eun Jo, Yeon-Sook Kim, Jeong Eun Lee, Young Kyung Yoon, Yu Bin Seo, Su Jin Jeong, Yu Min Kang, Eun-Jeong Joo, Jong Hyun Yoon, Sun Bean Kim, Ga Yeon Kim, Min-Kyung Kim
{"title":"Development and Roll-Out of A Coronavirus Disease 2019 Clinical Pathway for Standardized Qualified Care in Public Hospitals in Korea.","authors":"Mi Young Kwak,&nbsp;Eun Young Jo,&nbsp;BumSik Chin,&nbsp;Se Eun Park,&nbsp;Jun Yim,&nbsp;Jung Eun Lee,&nbsp;Kyung Eun Jo,&nbsp;Yeon-Sook Kim,&nbsp;Jeong Eun Lee,&nbsp;Young Kyung Yoon,&nbsp;Yu Bin Seo,&nbsp;Su Jin Jeong,&nbsp;Yu Min Kang,&nbsp;Eun-Jeong Joo,&nbsp;Jong Hyun Yoon,&nbsp;Sun Bean Kim,&nbsp;Ga Yeon Kim,&nbsp;Min-Kyung Kim","doi":"10.3947/ic.2022.0026","DOIUrl":null,"url":null,"abstract":"<p><p>Despite the coronavirus disease 2019 (COVID-19) vaccination roll-out, variant-related outbreaks have occurred repeatedly in Korea. Although public hospitals played a major role in COVID-19 patients' care, difficulty incorporating evolving COVID-19 treatment guidelines called for a clinical pathway (CP). Eighteen public hospitals volunteered, and a professional review board was created. CPs were formulated containing inclusion/exclusion criteria, application flow charts, and standardized order sets. After CP roll-out, key parameters improved, such as increased patient/staff five-point satisfaction scores (0.41/0.57) and decreased hospital stays (1.78 days)/medical expenses (17.5%). The CPs were updated consistently after roll-out as new therapeutics drugs were introduced and quarantine policies changed.</p>","PeriodicalId":520645,"journal":{"name":"Infection & chemotherapy","volume":" ","pages":"353-359"},"PeriodicalIF":2.9000,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/34/26/ic-54-353.PMC9259916.pdf","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infection & chemotherapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3947/ic.2022.0026","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Despite the coronavirus disease 2019 (COVID-19) vaccination roll-out, variant-related outbreaks have occurred repeatedly in Korea. Although public hospitals played a major role in COVID-19 patients' care, difficulty incorporating evolving COVID-19 treatment guidelines called for a clinical pathway (CP). Eighteen public hospitals volunteered, and a professional review board was created. CPs were formulated containing inclusion/exclusion criteria, application flow charts, and standardized order sets. After CP roll-out, key parameters improved, such as increased patient/staff five-point satisfaction scores (0.41/0.57) and decreased hospital stays (1.78 days)/medical expenses (17.5%). The CPs were updated consistently after roll-out as new therapeutics drugs were introduced and quarantine policies changed.

Abstract Image

Abstract Image

韩国公立医院标准化合格护理2019冠状病毒病临床路径的制定和推出
虽然韩国已经开始接种新冠病毒(COVID-19)疫苗,但与变异相关的疫情仍在不断发生。尽管公立医院在COVID-19患者的护理中发挥了重要作用,但由于难以纳入不断发展的COVID-19治疗指南,因此需要临床途径(CP)。18家公立医院自愿参加,并成立了一个专业审查委员会。CPs的制定包含纳入/排除标准、应用流程图和标准化顺序集。CP推出后,关键参数得到改善,如患者/员工五点满意度得分(0.41/0.57)增加,住院时间(1.78天)/医疗费用(17.5%)减少。随着新的治疗药物的引入和检疫政策的改变,CPs在推出后不断更新。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书